Rank | Gene Set | Z-score |
---|---|---|
1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.85660541 |
2 | skeletal muscle adaptation (GO:0043501) | 8.94095670 |
3 | skeletal muscle fiber development (GO:0048741) | 8.02758971 |
4 | plasma membrane repair (GO:0001778) | 7.70846960 |
5 | actin filament-based movement (GO:0030048) | 7.69919145 |
6 | myotube cell development (GO:0014904) | 6.88851496 |
7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.65171157 |
8 | striated muscle contraction (GO:0006941) | 6.50674392 |
9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.35364239 |
10 | glycogen catabolic process (GO:0005980) | 6.22861613 |
11 | creatine metabolic process (GO:0006600) | 6.18902166 |
12 | cytidine deamination (GO:0009972) | 6.17146197 |
13 | cytidine metabolic process (GO:0046087) | 6.17146197 |
14 | cytidine catabolic process (GO:0006216) | 6.17146197 |
15 | sarcomere organization (GO:0045214) | 6.02441151 |
16 | glucan catabolic process (GO:0009251) | 5.85903642 |
17 | cardiac myofibril assembly (GO:0055003) | 5.83953315 |
18 | carnitine shuttle (GO:0006853) | 5.79945118 |
19 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.79115547 |
20 | skeletal muscle tissue regeneration (GO:0043403) | 5.69061022 |
21 | purine nucleotide salvage (GO:0032261) | 5.61512501 |
22 | cellular polysaccharide catabolic process (GO:0044247) | 5.47657086 |
23 | myofibril assembly (GO:0030239) | 5.45241740 |
24 | muscle contraction (GO:0006936) | 5.40550151 |
25 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.33402881 |
26 | response to muscle activity (GO:0014850) | 5.28010908 |
27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.26187453 |
28 | polysaccharide catabolic process (GO:0000272) | 5.21882733 |
29 | regulation of cell communication by electrical coupling (GO:0010649) | 5.07559228 |
30 | response to inactivity (GO:0014854) | 4.99757122 |
31 | striated muscle atrophy (GO:0014891) | 4.96747898 |
32 | glycogen biosynthetic process (GO:0005978) | 4.85248704 |
33 | glucan biosynthetic process (GO:0009250) | 4.85248704 |
34 | fatty acid transmembrane transport (GO:1902001) | 4.84275744 |
35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.83344464 |
36 | muscle fiber development (GO:0048747) | 4.78536954 |
37 | muscle system process (GO:0003012) | 4.77379907 |
38 | striated muscle adaptation (GO:0014888) | 4.75258069 |
39 | IMP metabolic process (GO:0046040) | 4.66301953 |
40 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.65967518 |
41 | carnitine transport (GO:0015879) | 4.65522652 |
42 | amino-acid betaine transport (GO:0015838) | 4.65522652 |
43 | carnitine transmembrane transport (GO:1902603) | 4.61775281 |
44 | regulation of actin filament-based movement (GO:1903115) | 4.59280646 |
45 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.50290352 |
46 | muscle cell fate commitment (GO:0042693) | 4.49786399 |
47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.39323461 |
48 | cardiac muscle hypertrophy (GO:0003300) | 4.36119395 |
49 | muscle atrophy (GO:0014889) | 4.30919655 |
50 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.29880551 |
51 | actomyosin structure organization (GO:0031032) | 4.27822264 |
52 | glycogen metabolic process (GO:0005977) | 4.20187744 |
53 | striated muscle hypertrophy (GO:0014897) | 4.15822759 |
54 | neuronal action potential propagation (GO:0019227) | 4.13257506 |
55 | glucan metabolic process (GO:0044042) | 4.12587536 |
56 | cellular glucan metabolic process (GO:0006073) | 4.12587536 |
57 | cellular carbohydrate catabolic process (GO:0044275) | 3.98930618 |
58 | regulation of coenzyme metabolic process (GO:0051196) | 3.94981594 |
59 | regulation of cofactor metabolic process (GO:0051193) | 3.94981594 |
60 | tricarboxylic acid cycle (GO:0006099) | 3.94958467 |
61 | muscle organ morphogenesis (GO:0048644) | 3.93236300 |
62 | muscle tissue morphogenesis (GO:0060415) | 3.92259810 |
63 | quaternary ammonium group transport (GO:0015697) | 3.88065358 |
64 | response to activity (GO:0014823) | 3.86079645 |
65 | muscle adaptation (GO:0043500) | 3.83520451 |
66 | fructose metabolic process (GO:0006000) | 3.79919105 |
67 | regulation of myoblast differentiation (GO:0045661) | 3.79887752 |
68 | muscle organ development (GO:0007517) | 3.77428748 |
69 | muscle cell cellular homeostasis (GO:0046716) | 3.76991937 |
70 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75514278 |
71 | muscle structure development (GO:0061061) | 3.72876476 |
72 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.72080418 |
73 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.71729984 |
74 | cardiac muscle contraction (GO:0060048) | 3.71266478 |
75 | muscle hypertrophy (GO:0014896) | 3.70484914 |
76 | cardiac muscle cell development (GO:0055013) | 3.68893835 |
77 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.68085051 |
78 | regulation of relaxation of muscle (GO:1901077) | 3.66172959 |
79 | gluconeogenesis (GO:0006094) | 3.65965839 |
80 | negative regulation of muscle hypertrophy (GO:0014741) | 3.65531478 |
81 | neuromuscular synaptic transmission (GO:0007274) | 3.64140853 |
82 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.62076176 |
83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.59199601 |
84 | IMP biosynthetic process (GO:0006188) | 3.59096454 |
85 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.56526016 |
86 | regulation of the force of heart contraction (GO:0002026) | 3.53338722 |
87 | adult heart development (GO:0007512) | 3.52351753 |
88 | striated muscle cell development (GO:0055002) | 3.51609081 |
89 | positive regulation of myoblast differentiation (GO:0045663) | 3.51523152 |
90 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.46669133 |
91 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.46669133 |
92 | negative regulation of protein localization to cell surface (GO:2000009) | 3.45220796 |
93 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.44064514 |
94 | regulation of myotube differentiation (GO:0010830) | 3.40767365 |
95 | cardiac cell development (GO:0055006) | 3.40750354 |
96 | skeletal muscle tissue development (GO:0007519) | 3.40189458 |
97 | striated muscle tissue development (GO:0014706) | 3.37455270 |
98 | myoblast fusion (GO:0007520) | 3.33481949 |
99 | cellular response to dexamethasone stimulus (GO:0071549) | 3.33041321 |
100 | positive regulation of myotube differentiation (GO:0010831) | 3.31164072 |
101 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.30694288 |
102 | cardiac muscle adaptation (GO:0014887) | 3.29412354 |
103 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.29412354 |
104 | muscle hypertrophy in response to stress (GO:0003299) | 3.29412354 |
105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.29276016 |
106 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.26901334 |
107 | hexose biosynthetic process (GO:0019319) | 3.26124771 |
108 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.25294699 |
109 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.25294699 |
110 | regulation of muscle system process (GO:0090257) | 3.25056683 |
111 | regulation of skeletal muscle fiber development (GO:0048742) | 3.24337357 |
112 | myotube differentiation (GO:0014902) | 3.22963541 |
113 | neuromuscular junction development (GO:0007528) | 3.21804486 |
114 | regulation of sulfur metabolic process (GO:0042762) | 3.20830047 |
115 | negative regulation of muscle contraction (GO:0045932) | 3.17394018 |
116 | relaxation of muscle (GO:0090075) | 3.15793138 |
117 | response to mercury ion (GO:0046689) | 3.14873826 |
118 | NADH metabolic process (GO:0006734) | 3.09691754 |
119 | regulation of striated muscle contraction (GO:0006942) | 3.09191545 |
120 | response to dexamethasone (GO:0071548) | 3.09141167 |
121 | succinate metabolic process (GO:0006105) | 3.07126802 |
122 | lysine catabolic process (GO:0006554) | 3.06592122 |
123 | lysine metabolic process (GO:0006553) | 3.06592122 |
124 | valine metabolic process (GO:0006573) | 3.06242988 |
125 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.02916803 |
126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.98555169 |
127 | syncytium formation (GO:0006949) | 2.98031574 |
128 | muscle cell development (GO:0055001) | 2.97715434 |
129 | muscle filament sliding (GO:0030049) | 12.5121771 |
130 | actin-myosin filament sliding (GO:0033275) | 12.5121771 |
131 | regulation of skeletal muscle contraction (GO:0014819) | 11.9717658 |
132 | skeletal muscle contraction (GO:0003009) | 11.0428660 |
133 | actin-mediated cell contraction (GO:0070252) | 10.2604761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.00477435 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.17748276 |
3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.36708127 |
4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.03786510 |
5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.93839551 |
6 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.79085960 |
7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.77318310 |
8 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71527852 |
9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.45254897 |
10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.40517018 |
11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.29747515 |
12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.29747515 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10560658 |
14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05466430 |
15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.99788679 |
16 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87512197 |
17 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.86744361 |
18 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.70854894 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.70614849 |
20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69222374 |
21 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.68046669 |
22 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67658620 |
23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.65312208 |
24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.64353695 |
25 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.61343350 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55444943 |
27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53292212 |
28 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.52458458 |
29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51468140 |
30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51226919 |
31 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46046740 |
32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45924921 |
33 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.41643255 |
34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40733745 |
35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40332633 |
36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.40236072 |
37 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38638119 |
38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.34712859 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33992581 |
40 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33024878 |
41 | SA1_27219007_Chip-Seq_Bcells_Human | 1.30913946 |
42 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.29582355 |
43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.26230796 |
44 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24941502 |
45 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24230223 |
46 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24066473 |
47 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.20859961 |
48 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.20859961 |
49 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19995686 |
50 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18451633 |
51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18446232 |
52 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.15785451 |
53 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.13869019 |
54 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10729023 |
55 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09999330 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09942738 |
57 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09264925 |
58 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.08073618 |
59 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07456217 |
60 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05792607 |
61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05727534 |
62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05404350 |
63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04787346 |
64 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03237712 |
65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01763258 |
66 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.00639790 |
67 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.00214388 |
68 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99515464 |
69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98496343 |
70 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98168666 |
71 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97158754 |
72 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.96627976 |
73 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.96510289 |
74 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95711862 |
75 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95125293 |
76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95077559 |
77 | P68_20966046_ChIP-Seq_HELA_Human | 0.94516074 |
78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93001734 |
79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92889671 |
80 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.92178703 |
81 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90809374 |
82 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90512396 |
83 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90483121 |
84 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.90445655 |
85 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88889638 |
86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88816972 |
87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.88705783 |
88 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.88458491 |
89 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88427537 |
90 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.87348330 |
91 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87032748 |
92 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.86563561 |
93 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.86563561 |
94 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.86205267 |
95 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85579395 |
96 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85425028 |
97 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84068407 |
98 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.83928581 |
99 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.83757517 |
100 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.83545305 |
101 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.83372311 |
102 | CBP_21632823_ChIP-Seq_H3396_Human | 0.83286438 |
103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83177960 |
104 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82958176 |
105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.82677915 |
106 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.82368963 |
107 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.82289219 |
108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81471205 |
109 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.81265259 |
110 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81110142 |
111 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80998242 |
112 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80995042 |
113 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.80913868 |
114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80714907 |
115 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.80409735 |
116 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79861809 |
117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79337215 |
118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.79099952 |
119 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78444203 |
120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78382458 |
121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78036455 |
122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78013776 |
123 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77922654 |
124 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77655780 |
125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77533321 |
126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77504213 |
127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77451385 |
128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.76816834 |
129 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76536549 |
130 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.76474003 |
131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76432503 |
132 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.76366014 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 7.85726444 |
2 | MP0000749_muscle_degeneration | 6.48594677 |
3 | MP0003646_muscle_fatigue | 6.38207363 |
4 | MP0000751_myopathy | 5.71682746 |
5 | MP0000747_muscle_weakness | 4.65446661 |
6 | MP0002106_abnormal_muscle_physiology | 4.13824522 |
7 | MP0004036_abnormal_muscle_relaxation | 3.87864917 |
8 | * MP0000759_abnormal_skeletal_muscle | 3.63626978 |
9 | MP0002269_muscular_atrophy | 3.55412839 |
10 | MP0005369_muscle_phenotype | 3.45923007 |
11 | MP0002837_dystrophic_cardiac_calcinosis | 3.32366342 |
12 | * MP0004087_abnormal_muscle_fiber | 3.18933630 |
13 | MP0000750_abnormal_muscle_regeneration | 3.14702884 |
14 | MP0004130_abnormal_muscle_cell | 3.12341196 |
15 | * MP0005620_abnormal_muscle_contractility | 2.99375617 |
16 | MP0004233_abnormal_muscle_weight | 2.75810983 |
17 | MP0000733_abnormal_muscle_development | 2.30309550 |
18 | MP0002332_abnormal_exercise_endurance | 2.14340528 |
19 | MP0002108_abnormal_muscle_morphology | 2.02962176 |
20 | MP0006036_abnormal_mitochondrial_physio | 2.01036670 |
21 | MP0005330_cardiomyopathy | 1.89002148 |
22 | MP0004185_abnormal_adipocyte_glucose | 1.61359528 |
23 | MP0004043_abnormal_pH_regulation | 1.58287703 |
24 | MP0005666_abnormal_adipose_tissue | 1.57575563 |
25 | MP0002971_abnormal_brown_adipose | 1.51133073 |
26 | MP0008438_abnormal_cutaneous_collagen | 1.47815516 |
27 | MP0004084_abnormal_cardiac_muscle | 1.46487819 |
28 | MP0004270_analgesia | 1.42525133 |
29 | MP0004510_myositis | 1.42407258 |
30 | MP0004215_abnormal_myocardial_fiber | 1.37642655 |
31 | MP0004484_altered_response_of | 1.34750942 |
32 | MP0002972_abnormal_cardiac_muscle | 1.24937598 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.24660277 |
34 | MP0005375_adipose_tissue_phenotype | 1.14475866 |
35 | MP0003221_abnormal_cardiomyocyte_apopto | 1.08858614 |
36 | MP0010630_abnormal_cardiac_muscle | 1.06932183 |
37 | MP0001661_extended_life_span | 1.05697342 |
38 | MP0006035_abnormal_mitochondrial_morpho | 1.04168616 |
39 | MP0000013_abnormal_adipose_tissue | 1.03076698 |
40 | MP0005266_abnormal_metabolism | 1.01427490 |
41 | MP0005503_abnormal_tendon_morphology | 0.98729848 |
42 | MP0003950_abnormal_plasma_membrane | 0.96627412 |
43 | MP0005670_abnormal_white_adipose | 0.95979272 |
44 | MP0009780_abnormal_chondrocyte_physiolo | 0.94964858 |
45 | MP0008961_abnormal_basal_metabolism | 0.86220827 |
46 | MP0004134_abnormal_chest_morphology | 0.84037947 |
47 | MP0005385_cardiovascular_system_phenoty | 0.79162725 |
48 | MP0001544_abnormal_cardiovascular_syste | 0.79162725 |
49 | MP0003705_abnormal_hypodermis_morpholog | 0.78168027 |
50 | MP0004147_increased_porphyrin_level | 0.77396579 |
51 | MP0003279_aneurysm | 0.76198168 |
52 | MP0003137_abnormal_impulse_conducting | 0.75526829 |
53 | MP0003828_pulmonary_edema | 0.74327342 |
54 | MP0002139_abnormal_hepatobiliary_system | 0.72981242 |
55 | MP0000372_irregular_coat_pigmentation | 0.70007690 |
56 | MP0009250_abnormal_appendicular_skeleto | 0.69600626 |
57 | MP0003195_calcinosis | 0.68841553 |
58 | MP0001765_abnormal_ion_homeostasis | 0.67611833 |
59 | MP0002234_abnormal_pharynx_morphology | 0.66772298 |
60 | MP0001299_abnormal_eye_distance/ | 0.66618344 |
61 | MP0000762_abnormal_tongue_morphology | 0.66524598 |
62 | MP0005360_urolithiasis | 0.66096039 |
63 | MP0002078_abnormal_glucose_homeostasis | 0.65506388 |
64 | MP0002822_catalepsy | 0.64558265 |
65 | MP0010030_abnormal_orbit_morphology | 0.63648600 |
66 | MP0005332_abnormal_amino_acid | 0.63267333 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62677827 |
68 | MP0001958_emphysema | 0.61490258 |
69 | MP0000003_abnormal_adipose_tissue | 0.60782034 |
70 | MP0003879_abnormal_hair_cell | 0.59605716 |
71 | MP0003656_abnormal_erythrocyte_physiolo | 0.59298576 |
72 | MP0002896_abnormal_bone_mineralization | 0.58044326 |
73 | MP0005334_abnormal_fat_pad | 0.57178485 |
74 | MP0002089_abnormal_postnatal_growth/wei | 0.54595949 |
75 | MP0004272_abnormal_basement_membrane | 0.54373653 |
76 | MP0003959_abnormal_lean_body | 0.53597173 |
77 | MP0005275_abnormal_skin_tensile | 0.53172327 |
78 | MP0005083_abnormal_biliary_tract | 0.51705025 |
79 | MP0002128_abnormal_blood_circulation | 0.50110833 |
80 | MP0005319_abnormal_enzyme/_coenzyme | 0.49632279 |
81 | MP0005636_abnormal_mineral_homeostasis | 0.49138530 |
82 | MP0005452_abnormal_adipose_tissue | 0.49033826 |
83 | MP0008775_abnormal_heart_ventricle | 0.48599878 |
84 | MP0002127_abnormal_cardiovascular_syste | 0.48239588 |
85 | MP0009384_cardiac_valve_regurgitation | 0.46315394 |
86 | MP0002249_abnormal_larynx_morphology | 0.45357601 |
87 | MP0008569_lethality_at_weaning | 0.45141765 |
88 | MP0005451_abnormal_body_composition | 0.44240238 |
89 | MP0000266_abnormal_heart_morphology | 0.44175969 |
90 | MP0000343_altered_response_to | 0.43316123 |
91 | MP0001542_abnormal_bone_strength | 0.43080932 |
92 | MP0000230_abnormal_systemic_arterial | 0.42491592 |
93 | MP0002138_abnormal_hepatobiliary_system | 0.41936755 |
94 | MP0005535_abnormal_body_temperature | 0.41170826 |
95 | MP0003045_fibrosis | 0.40602924 |
96 | MP0009672_abnormal_birth_weight | 0.40153455 |
97 | MP0001346_abnormal_lacrimal_gland | 0.38122750 |
98 | MP0004142_abnormal_muscle_tone | 0.36041496 |
99 | MP0003941_abnormal_skin_development | 0.35948843 |
100 | MP0005165_increased_susceptibility_to | 0.35102625 |
101 | MP0002114_abnormal_axial_skeleton | 0.34878178 |
102 | MP0000534_abnormal_ureter_morphology | 0.34702753 |
103 | MP0009115_abnormal_fat_cell | 0.32506925 |
104 | MP0009643_abnormal_urine_homeostasis | 0.31566043 |
105 | MP0002118_abnormal_lipid_homeostasis | 0.31107931 |
106 | MP0003948_abnormal_gas_homeostasis | 0.30638020 |
107 | MP0010368_abnormal_lymphatic_system | 0.30578983 |
108 | MP0005187_abnormal_penis_morphology | 0.30389395 |
109 | MP0006138_congestive_heart_failure | 0.30193917 |
110 | MP0003252_abnormal_bile_duct | 0.29298733 |
111 | MP0000767_abnormal_smooth_muscle | 0.28879859 |
112 | MP0000383_abnormal_hair_follicle | 0.26823927 |
113 | MP0005595_abnormal_vascular_smooth | 0.26522349 |
114 | MP0000579_abnormal_nail_morphology | 0.25869526 |
115 | MP0005166_decreased_susceptibility_to | 0.24917164 |
116 | MP0002796_impaired_skin_barrier | 0.24706587 |
117 | MP0002066_abnormal_motor_capabilities/c | 0.24678527 |
118 | MP0005376_homeostasis/metabolism_phenot | 0.23245173 |
119 | MP0005623_abnormal_meninges_morphology | 0.22876645 |
120 | MP0004085_abnormal_heartbeat | 0.22861785 |
121 | MP0003385_abnormal_body_wall | 0.22815248 |
122 | MP0001849_ear_inflammation | 0.21148631 |
123 | MP0001943_abnormal_respiration | 0.21094817 |
124 | MP0004019_abnormal_vitamin_homeostasis | 0.19435239 |
125 | MP0004858_abnormal_nervous_system | 0.17890588 |
126 | MP0005377_hearing/vestibular/ear_phenot | 0.16950633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.78108597 |
2 | Nemaline bodies (HP:0003798) | 9.38024102 |
3 | Exercise-induced myalgia (HP:0003738) | 8.48700055 |
4 | Exercise-induced muscle cramps (HP:0003710) | 7.72883823 |
5 | Type 1 muscle fiber predominance (HP:0003803) | 7.67802174 |
6 | Distal arthrogryposis (HP:0005684) | 7.40657308 |
7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.90306049 |
8 | Myopathic facies (HP:0002058) | 6.78738359 |
9 | Calf muscle hypertrophy (HP:0008981) | 6.16416305 |
10 | Round ear (HP:0100830) | 6.07742981 |
11 | Ulnar deviation of the wrist (HP:0003049) | 6.05481711 |
12 | Difficulty running (HP:0009046) | 5.23996314 |
13 | Calcaneovalgus deformity (HP:0001848) | 5.18603719 |
14 | Muscle fiber splitting (HP:0003555) | 5.10910740 |
15 | Myoglobinuria (HP:0002913) | 5.06977038 |
16 | Absent phalangeal crease (HP:0006109) | 4.79916740 |
17 | Deformed tarsal bones (HP:0008119) | 4.71217214 |
18 | Muscle stiffness (HP:0003552) | 4.63221113 |
19 | Hyporeflexia of lower limbs (HP:0002600) | 4.55098615 |
20 | EMG: myopathic abnormalities (HP:0003458) | 4.48297245 |
21 | Rhabdomyolysis (HP:0003201) | 4.20663502 |
22 | Increased connective tissue (HP:0009025) | 4.16686897 |
23 | Abnormality of the calf musculature (HP:0001430) | 4.13410732 |
24 | Abnormal finger flexion creases (HP:0006143) | 4.01168699 |
25 | Myotonia (HP:0002486) | 3.94299360 |
26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.85094359 |
27 | Neck muscle weakness (HP:0000467) | 3.53536584 |
28 | Malignant hyperthermia (HP:0002047) | 3.50708508 |
29 | Subaortic stenosis (HP:0001682) | 3.43661091 |
30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.43661091 |
31 | Rimmed vacuoles (HP:0003805) | 3.39832265 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.34594722 |
33 | Frequent falls (HP:0002359) | 3.32931572 |
34 | Difficulty climbing stairs (HP:0003551) | 3.26768651 |
35 | Shoulder girdle muscle weakness (HP:0003547) | 3.17835853 |
36 | Pelvic girdle muscle weakness (HP:0003749) | 3.16522892 |
37 | Abnormality of the calcaneus (HP:0008364) | 3.10446132 |
38 | Hyperkalemia (HP:0002153) | 3.08049611 |
39 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.06051120 |
40 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.06051120 |
41 | Areflexia of lower limbs (HP:0002522) | 2.95825221 |
42 | Asymmetric septal hypertrophy (HP:0001670) | 2.86894463 |
43 | Bundle branch block (HP:0011710) | 2.82318594 |
44 | Slender build (HP:0001533) | 2.73343068 |
45 | Paralysis (HP:0003470) | 2.56774215 |
46 | Generalized muscle weakness (HP:0003324) | 2.55271653 |
47 | Distal lower limb muscle weakness (HP:0009053) | 2.54052195 |
48 | Abnormality of the neuromuscular junction (HP:0003398) | 2.47201670 |
49 | Fatigable weakness (HP:0003473) | 2.47201670 |
50 | EMG: neuropathic changes (HP:0003445) | 2.42860962 |
51 | Sudden death (HP:0001699) | 2.42113947 |
52 | Muscular dystrophy (HP:0003560) | 2.34311996 |
53 | Gout (HP:0001997) | 2.31739182 |
54 | Proximal amyotrophy (HP:0007126) | 2.30702654 |
55 | Bulbar palsy (HP:0001283) | 2.30544286 |
56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.28286076 |
57 | Nonprogressive disorder (HP:0003680) | 2.26442891 |
58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26350773 |
59 | Lipoatrophy (HP:0100578) | 2.24139884 |
60 | Popliteal pterygium (HP:0009756) | 2.19907751 |
61 | Spinal rigidity (HP:0003306) | 2.13822947 |
62 | Limb-girdle muscle weakness (HP:0003325) | 2.12794996 |
63 | Metatarsus adductus (HP:0001840) | 2.12098745 |
64 | Increased purine levels (HP:0004368) | 2.11489394 |
65 | Hyperuricemia (HP:0002149) | 2.11489394 |
66 | Weak cry (HP:0001612) | 2.10327156 |
67 | Facial diplegia (HP:0001349) | 2.07540122 |
68 | Gowers sign (HP:0003391) | 2.06155657 |
69 | Progressive muscle weakness (HP:0003323) | 2.06013403 |
70 | Hypoplastic ischia (HP:0003175) | 2.05310098 |
71 | Fetal akinesia sequence (HP:0001989) | 2.04729114 |
72 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.03175123 |
73 | Limb-girdle muscle atrophy (HP:0003797) | 2.02017343 |
74 | Scapular winging (HP:0003691) | 2.01970758 |
75 | Muscle fiber inclusion bodies (HP:0100299) | 10.3129061 |
76 | Ulnar deviation of finger (HP:0009465) | 1.97231259 |
77 | Breech presentation (HP:0001623) | 1.94435191 |
78 | Hip contracture (HP:0003273) | 1.92971665 |
79 | Abnormality of potassium homeostasis (HP:0011042) | 1.91446740 |
80 | Waddling gait (HP:0002515) | 1.90428161 |
81 | Abnormality of the foot musculature (HP:0001436) | 1.86610197 |
82 | Heart block (HP:0012722) | 1.86372757 |
83 | Distal lower limb amyotrophy (HP:0008944) | 1.84585416 |
84 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.83471181 |
85 | Abnormal atrioventricular conduction (HP:0005150) | 1.79987567 |
86 | Abnormality of the ischium (HP:0003174) | 1.78763940 |
87 | Hypokalemia (HP:0002900) | 1.76127703 |
88 | Achilles tendon contracture (HP:0001771) | 1.75215139 |
89 | Long clavicles (HP:0000890) | 1.75056404 |
90 | Foot dorsiflexor weakness (HP:0009027) | 1.72918330 |
91 | Aplasia of the musculature (HP:0100854) | 1.65638734 |
92 | Abnormality of the Achilles tendon (HP:0005109) | 1.65178015 |
93 | Type 2 muscle fiber atrophy (HP:0003554) | 1.60823272 |
94 | Ragged-red muscle fibers (HP:0003200) | 1.60288794 |
95 | Amniotic constriction ring (HP:0009775) | 1.56244618 |
96 | Abnormality of placental membranes (HP:0011409) | 1.56244618 |
97 | Ventricular arrhythmia (HP:0004308) | 1.55971072 |
98 | Ventricular tachycardia (HP:0004756) | 1.54603014 |
99 | Stridor (HP:0010307) | 1.53773579 |
100 | Increased density of long bones (HP:0006392) | 1.53422761 |
101 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.53039855 |
102 | Tarsal synostosis (HP:0008368) | 1.51780995 |
103 | Muscle fiber atrophy (HP:0100295) | 1.51751874 |
104 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.49105356 |
105 | Short palpebral fissure (HP:0012745) | 1.45786917 |
106 | Cholelithiasis (HP:0001081) | 1.44608964 |
107 | Congenital hip dislocation (HP:0001374) | 1.42493708 |
108 | Abnormality of purine metabolism (HP:0004352) | 1.41905049 |
109 | Adducted thumb (HP:0001181) | 1.41804423 |
110 | Dilated cardiomyopathy (HP:0001644) | 1.38953495 |
111 | Ketoacidosis (HP:0001993) | 1.37908984 |
112 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.36822990 |
113 | Synostosis involving bones of the feet (HP:0009140) | 1.36822990 |
114 | Lower limb amyotrophy (HP:0007210) | 1.36243040 |
115 | Exercise intolerance (HP:0003546) | 1.33748974 |
116 | Limited hip movement (HP:0008800) | 1.31041349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 9.25493925 |
2 | TTN | 6.08645890 |
3 | PHKG2 | 5.27227679 |
4 | PHKG1 | 5.27227679 |
5 | NME1 | 4.05005653 |
6 | PIK3CG | 3.99546262 |
7 | MAP2K3 | 2.74320761 |
8 | NEK1 | 2.38412467 |
9 | MAP3K7 | 2.21325382 |
10 | PINK1 | 2.19361383 |
11 | BCKDK | 2.05712259 |
12 | PDK3 | 2.05416452 |
13 | PDK4 | 2.05416452 |
14 | DMPK | 1.65526978 |
15 | MAPK12 | 1.64353484 |
16 | TRIB3 | 1.57696801 |
17 | MAP2K4 | 1.57126232 |
18 | PIK3CA | 1.45176040 |
19 | MAP2K6 | 1.45061309 |
20 | PDK2 | 1.34467234 |
21 | MUSK | 1.24642092 |
22 | MARK1 | 0.98508616 |
23 | PRKAA2 | 0.86131223 |
24 | PRKAA1 | 0.84877589 |
25 | MAP3K3 | 0.82376774 |
26 | TAOK2 | 0.78996227 |
27 | MYLK | 0.76477448 |
28 | WNK4 | 0.71328672 |
29 | MAP3K13 | 0.71137840 |
30 | OXSR1 | 0.69951370 |
31 | MAPK11 | 0.69726665 |
32 | NEK9 | 0.69177836 |
33 | DDR2 | 0.64568273 |
34 | AKT2 | 0.59935397 |
35 | MAPKAPK3 | 0.59781488 |
36 | ERBB3 | 0.58463741 |
37 | CAMK4 | 0.58225232 |
38 | WNK3 | 0.55377051 |
39 | TRPM7 | 0.54384393 |
40 | CAMK2G | 0.53904309 |
41 | EPHB1 | 0.53587978 |
42 | RIPK1 | 0.52642647 |
43 | STK24 | 0.52474042 |
44 | SIK1 | 0.52033345 |
45 | MAP3K11 | 0.47404724 |
46 | CAMK1 | 0.45441759 |
47 | TAOK1 | 0.45290866 |
48 | PKN2 | 0.44869082 |
49 | SGK1 | 0.43651858 |
50 | ZAK | 0.41407177 |
51 | CAMK2B | 0.41103034 |
52 | CAMK2A | 0.40820992 |
53 | PTK6 | 0.37468987 |
54 | PRPF4B | 0.37174301 |
55 | PDGFRA | 0.34062782 |
56 | ARAF | 0.33822795 |
57 | LIMK1 | 0.29912218 |
58 | PRKACB | 0.28002910 |
59 | TBK1 | 0.26598091 |
60 | TIE1 | 0.26443829 |
61 | RPS6KL1 | 0.26355847 |
62 | RPS6KC1 | 0.26355847 |
63 | PRKG1 | 0.25842136 |
64 | ILK | 0.25578571 |
65 | AKT3 | 0.25563484 |
66 | CDC42BPA | 0.25272784 |
67 | RPS6KA3 | 0.24794966 |
68 | STK38L | 0.24263380 |
69 | MARK2 | 0.24240843 |
70 | LATS1 | 0.24035254 |
71 | PKN1 | 0.23446906 |
72 | MAP3K6 | 0.22902803 |
73 | SGK3 | 0.22299038 |
74 | RPS6KA2 | 0.21698441 |
75 | PRKACA | 0.20886492 |
76 | PAK6 | 0.20730647 |
77 | MAP3K5 | 0.20467374 |
78 | RPS6KB1 | 0.19831521 |
79 | MAPK4 | 0.19807766 |
80 | PDPK1 | 0.19466901 |
81 | RPS6KA6 | 0.19311595 |
82 | ROCK1 | 0.18695122 |
83 | INSRR | 0.17980080 |
84 | KSR2 | 0.17829820 |
85 | WNK1 | 0.17392936 |
86 | MAP3K1 | 0.17274837 |
87 | RPS6KB2 | 0.17240676 |
88 | TESK1 | 0.16917216 |
89 | MAP2K1 | 0.16092521 |
90 | CAMK1G | 0.15361919 |
91 | DYRK1B | 0.15270387 |
92 | MAPK7 | 0.15079555 |
93 | STK39 | 0.14325097 |
94 | STK38 | 0.14179415 |
95 | PDK1 | 0.13922112 |
96 | CDK19 | 0.13779504 |
97 | ICK | 0.12713349 |
98 | EEF2K | 0.11584764 |
99 | RAF1 | 0.10269090 |
100 | PAK2 | 0.10006351 |
101 | ABL2 | 0.09768153 |
102 | BRAF | 0.09451392 |
103 | PRKD1 | 0.09414790 |
104 | SGK2 | 0.09393467 |
105 | LRRK2 | 0.08530920 |
106 | MAP3K10 | 0.08334936 |
107 | SGK223 | 0.08318721 |
108 | SGK494 | 0.08318721 |
109 | PRKD2 | 0.06733835 |
110 | PRKACG | 0.06568288 |
111 | STK11 | 0.06477243 |
112 | ZAP70 | 0.06020315 |
113 | GSK3A | 0.05993863 |
114 | MAP3K4 | 0.05817022 |
115 | PAK1 | 0.05511967 |
116 | MAPK13 | 0.05406777 |
117 | MST1R | 0.05358691 |
118 | LATS2 | 0.05330316 |
119 | KSR1 | 0.04210021 |
120 | RPS6KA1 | 0.03190131 |
121 | MAPK10 | 0.02761745 |
122 | CCNB1 | 0.02588882 |
123 | CAMK2D | 0.02458872 |
124 | TGFBR2 | 0.02386589 |
125 | MOS | 0.02368596 |
126 | BMX | 0.01746461 |
127 | MAPK8 | 0.01322845 |
128 | PTK2B | 0.01258468 |
129 | MTOR | 0.01190249 |
130 | FGFR1 | 0.00961393 |
131 | JAK2 | -0.0037876 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.39917541 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.67166669 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.62353795 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.28943266 |
5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.20646922 |
6 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.02900336 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.99332707 |
8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.91857882 |
9 | Carbon metabolism_Homo sapiens_hsa01200 | 2.32475868 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21653277 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14117156 |
12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.09680295 |
13 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.08726672 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96437461 |
15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.96070266 |
16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.90237790 |
17 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.86799445 |
18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.85943885 |
19 | Insulin resistance_Homo sapiens_hsa04931 | 1.79956673 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.67607632 |
21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66753769 |
22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.58638908 |
23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.56814688 |
24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.55187945 |
25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54039209 |
26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.53969563 |
27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53800509 |
28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.49569223 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48482056 |
30 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.46643721 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45202629 |
32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44754742 |
33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38958330 |
34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.38607824 |
35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.26555165 |
36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24688978 |
37 | Tight junction_Homo sapiens_hsa04530 | 1.18595358 |
38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.16723201 |
39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16107955 |
40 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13719652 |
41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08690081 |
42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03614889 |
43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00625524 |
44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.99033910 |
45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96942394 |
46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83185917 |
47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82907552 |
48 | Long-term potentiation_Homo sapiens_hsa04720 | 0.81429547 |
49 | Peroxisome_Homo sapiens_hsa04146 | 0.79820755 |
50 | Focal adhesion_Homo sapiens_hsa04510 | 0.77089116 |
51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75065922 |
52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73212355 |
53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71064664 |
54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69529828 |
55 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65800568 |
56 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65056345 |
57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64621401 |
58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63354841 |
59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62275583 |
60 | Bile secretion_Homo sapiens_hsa04976 | 0.59570208 |
61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.58839189 |
62 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57094690 |
63 | Insulin secretion_Homo sapiens_hsa04911 | 0.51952547 |
64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51538681 |
65 | Renin secretion_Homo sapiens_hsa04924 | 0.50895635 |
66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45749928 |
67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45089613 |
68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44291552 |
69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43970574 |
70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.43287364 |
71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42256429 |
72 | Salivary secretion_Homo sapiens_hsa04970 | 0.40945774 |
73 | Melanogenesis_Homo sapiens_hsa04916 | 0.40779156 |
74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40777257 |
75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39979824 |
76 | Glioma_Homo sapiens_hsa05214 | 0.39260342 |
77 | Lysine degradation_Homo sapiens_hsa00310 | 0.38263589 |
78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36446124 |
79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35854467 |
80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34659648 |
81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33934915 |
82 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31915299 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30239866 |
84 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.30226288 |
85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30074042 |
86 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29317331 |
87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27428923 |
88 | Platelet activation_Homo sapiens_hsa04611 | 0.26982215 |
89 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.25177297 |
90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25002648 |
91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24984761 |
92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23765896 |
93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23644743 |
94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23121375 |
95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23060536 |
96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.22908865 |
97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21817925 |
98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.21636326 |
99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20222608 |
100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19890201 |
101 | Long-term depression_Homo sapiens_hsa04730 | 0.19660015 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.19023532 |
103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17855137 |
104 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.17827173 |
105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.16999126 |
106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.16677543 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16184715 |
108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15954933 |
109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.14433111 |
110 | Adherens junction_Homo sapiens_hsa04520 | 0.13734037 |
111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.13022916 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12558952 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.10120218 |
114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.08983297 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.08134602 |
116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.06471261 |
117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.05428626 |